Sphingolipids and their role in health and disease in the central nervous system

Q1 Biochemistry, Genetics and Molecular Biology
Andrés Felipe Leal , Diego A. Suarez , Olga Yaneth Echeverri-Peña , Sonia Luz Albarracín , Carlos Javier Alméciga-Díaz , Ángela Johana Espejo-Mojica
{"title":"Sphingolipids and their role in health and disease in the central nervous system","authors":"Andrés Felipe Leal ,&nbsp;Diego A. Suarez ,&nbsp;Olga Yaneth Echeverri-Peña ,&nbsp;Sonia Luz Albarracín ,&nbsp;Carlos Javier Alméciga-Díaz ,&nbsp;Ángela Johana Espejo-Mojica","doi":"10.1016/j.jbior.2022.100900","DOIUrl":null,"url":null,"abstract":"<div><p><span>Sphingolipids<span> (SLs) are lipids<span> derived from sphingosine, and their metabolism involves a broad and complex network of reactions. Although SLs are widely distributed in the body, it is well known that they are present in high concentrations within the central nervous system (CNS). Under physiological conditions, their abundance and distribution in the CNS depend on brain development and cell type. Consequently, </span></span></span>SLs metabolism<span><span> impairment may have a significant impact on the normal CNS function, and has been associated with several disorders, including </span>sphingolipidoses, Parkinson's, and Alzheimer's. This review summarizes the main SLs characteristics and current knowledge about synthesis, catabolism, regulatory pathways, and their role in physiological and pathological scenarios in the CNS.</span></p></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"85 ","pages":"Article 100900"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in biological regulation","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212492622000409","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 6

Abstract

Sphingolipids (SLs) are lipids derived from sphingosine, and their metabolism involves a broad and complex network of reactions. Although SLs are widely distributed in the body, it is well known that they are present in high concentrations within the central nervous system (CNS). Under physiological conditions, their abundance and distribution in the CNS depend on brain development and cell type. Consequently, SLs metabolism impairment may have a significant impact on the normal CNS function, and has been associated with several disorders, including sphingolipidoses, Parkinson's, and Alzheimer's. This review summarizes the main SLs characteristics and current knowledge about synthesis, catabolism, regulatory pathways, and their role in physiological and pathological scenarios in the CNS.

鞘脂及其在中枢神经系统健康和疾病中的作用
鞘脂(SLs)是鞘磷脂衍生的脂质,其代谢涉及广泛而复杂的反应网络。虽然SLs在体内广泛分布,但众所周知,它们在中枢神经系统(CNS)中以高浓度存在。在生理条件下,它们在中枢神经系统中的丰度和分布取决于大脑发育和细胞类型。因此,SLs代谢障碍可能对正常的中枢神经系统功能产生重大影响,并与多种疾病有关,包括鞘脂病、帕金森病和阿尔茨海默病。本文综述了SLs的主要特性、合成、分解代谢、调控途径及其在中枢神经系统生理和病理中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in biological regulation
Advances in biological regulation Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
0.00%
发文量
41
审稿时长
17 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信